Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS

Detalles Bibliográficos
Autores principales: Gregory, Gareth P., Dickinson, Michael, Yannakou, Costas K., Wong, Jonathan, Blombery, Piers, Corboy, Greg, Kats, Lev, Crozier, Tim M.E., Kumar, Beena, Prince, H. Miles, Opat, Stephen S., Shortt, Jake
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746031/
https://www.ncbi.nlm.nih.gov/pubmed/31723826
http://dx.doi.org/10.1097/HS9.0000000000000187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746031/
https://www.ncbi.nlm.nih.gov/pubmed/31723826
http://dx.doi.org/10.1097/HS9.0000000000000187

Ejemplares similares